The Virginia Neurological Society
The Virginia Neurological Society was founded in 1972 with the purpose of advancing the science of neurology in Virginia. The VNS provides its members with a collective voice in matters that concern the practice of neurology and education in the field of neurology. Members are also represented at the state medical society level where legislative and regulatory issues are brought to focus in the area of neurology.
The first meeting of the VNS was held at the Bull and Bear Club in Richmond, Virginia with 28 neurologists in attendance. Today, the VNS has 138 members and continues to grow every year. The highlight of society membership includes the opportunity to attend the VNS Annual Meeting traditionally held at The Omni Homestead Resort in Hot Springs, VA. The 2020 meeting marked the 48th annual meeting giving the Virginia Neurological Society the record for the longest consecutively run meeting of any state society.
The Virginia Neurological Society boasts a long tradition of excellence in education, statewide representation, and comradery and we invite you to join us as we continue to grow, share ideas, and strive to improve the practice of neurology in the state of Virginia.
SAVE THE DATE
2026 VNS Annual Meeting
The VNS Annual Meeting will take place January 22-25, 2026 at the Omni Homestead Resort, Hot Springs, VA . Meeting details and registration forms will be emailed in mid September. If you do not receive an email with the information please contact Sona Pomfret, VNS Executive Director at vaneurosoc@gmail.com to update your contact info.
ANNOUNCEMENTS:
Future VNS Annual Meeting Dates at The Omni Homestead Resort:
January 22-25, 2026
January 21-24, 2027
January 20-23, 2028
****************
The University of Virginia School of Medicine Department of Neurology is conducting a research survey study evaluating the care of patients with idiopathic normal pressure hydrocephalus (iNPH).
If you would like to learn more about the survey, please use the QR code below for further details.
The survey and consent form can be accessed through the QR codes below:
iNPH Survey Consent Form
***************
The Guthy-Jackson Charitable Foundation (GJCF) NMOSD Grand Rounds program aims to inform practicing neurology specialists as well as the broader spectrum of neurologists and allied healthcare providers regarding latest information in evidence-based science and medicine of NMOSD. This program features 12 essential topics addressed by experts in the field at a monthly interval. Organized and curated by GJCF advisors, this series of educational webinars enables continuing medical education (CME) credit.
This professional education opportunity comes at no cost to you. Each session will remain accessible and CME-eligible for one year following its release. For more details, including topics, speakers, and release dates, please visit our new Education Center or view our NMOSD Grand Rounds Schedule. To help disseminate this valuable resource, we also encourage you to share this information with colleagues and others who may benefit.
Session 5 Now Available
Session 5 entitled Toward Harmonized Relapse Adjudication & Severity and presented by Brian Weinshenker, MD of the University of Virginia is now available. This session is designed to update knowledge important for understanding the signs, symptoms and definitions of relapse events in relation to specific therapeutic regimens or a lack thereof. Specific discussion points in this regard include anatomic localization, targeted neurologic deficits, and severity score for events adjudicated to be relapses.
Other Available Sessions
Session 1: Diagnosis & Differential Diagnosis of NMOSD presented by
Dean Wingerchuk, MD, MSc, FRCP(C) – CME Eligible through February 28, 2026
Session 2: Emerging Principles & Practices for Imaging presented by
Frederike Oertel, MD, PhD – CME Eligible through March 28, 2026
Session 3: Therapeutic Decision-Making: Mechanisms & Rationale presented by Jeffrey Bennett, MD, PhD – CME Eligible through April 25, 2026
Session 4: Pathogenesis & Immunologic Targets presented by
Scott Zamvil, MD, PhD – CME Eligible through May 9, 2026